Corporate Governance

Main Menu

Audit Committee

Audit Committee Members

Organizer: Wei-Min, Zhuang

  • Professional Qualifications and Experience: Mr. Zhuang was an Accounting Supervisor at MicroBase Technology Corp., (3184) from 2002 to 2011; from 2014 to 2015 he was Chief Financial Officer at DV Biomed Co., Ltd. (6539); and from 2016 he works as Director of Finance and Management Department and Accounting Supervisor at Kwan’s International Co., Ltd. (6101).

Member: Yi-Ping, Chen

  • Professional Qualification and Experience: Ms. Chen was the Investment Associate and Vice President of CTC Capital Inc. She was an investment officer at Cathay Life Insurance Project Investment Division and the investment manager of its subsidiary, Etek Investment Management Consultants, Inc. From 2004 to Jan 2007, she was the Financial Manager at Chardin Tech Corp. Ms. Chen is currently the founder and managing partner of For Win Assets Management Ltd. She has more than two decades of experiences in finance and venture capital, and has worked as director of several companies. Ms. Chen has Master’s Degree in Finance and Bachelor’s Degree in Economics from National Taiwan University.

Member: Jun-Yi, Lin

  • Professional Qualification and Experience: From 2002 to April 2013, Mr. Lin served as a prosecutor at the New Taipei City District Attorney’s Office and a resident prosecutor at the Independent Commission Against Corruption (ICAC); he has been the presiding attorney of Hengsheng Law Firm since April 2013. Mr. Lin has over 21 years of experience in legal practice and is familiar with the domestic securities market and business laws and regulations.

Member: Ding-Jun, Zhong

Audit Committee Role and Responsibilities

The main purpose is to supervise the following of:

  1. The fair representation of the Company’s financial statements.
  2. Appointment or dismissal of attesting CPAs and evaluation of CPAs’ independence and performance.
  3. Effective implementation of the Company’s internal control.
  4. The Company’s compliance with relevant laws and regulations.
  5. The Company’s management of existing or potential risks.

The annual work highlights of the Audit Committee are summarized as follows:

  1. Establish or amend the internal control system.
  2. Evaluation of the effectiveness of the internal control system.
  3. Establish or revise the management practices or operating procedures, such as handling procedures for the acquisition or disposal of assets, engagement in derivative transactions, loaning of funds to others, provisions of endorsement or guarantee to others, and other significant financial or business actions.
  4. Matters involving the personal interest of directors.
  5. Asset transactions or derivatives trading of a material nature.
  6. Loans of funds, endorsements or provision of guarantees of a material nature.
  7. The offering, issuance, or private placement of equity-type securities.
  8. The hiring or dismissal of a CPA, or their compensation.
  9. The appointment or discharge of a financial, accounting, or internal Audit Officer.
  10. The financial reports.

Financial Statement Audit

The Board of Directors has issued a report on the Company’s operation for the fiscal year 2021, the financial statements, and earnings distribution proposals. We have the financial statements audited by PwC, and the audited report has been issued. In the business report mentioned above, the financial statements and distribution of earnings have been audited by the Audit Committee, and the result showed no inconsistency.

Appraisal of the Effectiveness of the Internal Control System

The effectiveness of the design and implementation of the internal control system is assessed by each department, reviewed by the Audit Office, and audited by the Audit Committee.

Loans of Funds, Endorsements or Provision of Guarantees of a Material Nature

After prudent evaluation, the financial department proposes a relevant fund loan of funds, endorsement, guarantee, etc, to be discussed and approved by the Audit Committee.

Amendment on Internal Control System

Amendments to the relevant internal controls and practices proposed by each executive unit shall be discussed and approved by the Audit Committee.

Audit Committee meeting information

Meeting SessionAgenda ItemsResults of Resolutions, and the Company’s handling of the Audit Committee’s Opinion
The16th Session of the Second Meeting
2023/03/16		1. The company’s 2022 business report, financial statements and consolidated financial statements.
2. The company’s 2022 earnings distribution plan
3. The case of distributing the company’s 2022surplus in cash
4. The company and its subsidiaries plan to handle short-term financing quota cases
5. The company's subsidiary plans to apply for short-term financing from the bank, and the company plans to endorse it.
6. Cases in which the company and its subsidiaries intend to lend funds to their subsidiaries
7. Amend some provisions of the company's "Articles of Association"
8. Amend some provisions of the company’s “Corporate Governance Code”
9. Revise part of the company's "Internal Management Cycle - Related Party Transaction Management Operations"
10. Revise some provisions of the company’s “Code of Practice for Sustainable Development”
11. Submit the company’s 2022 internal control system statement
12. The company’s 2023 appointment of accountants and independence assessment
13. Accountants who intend to be pre-approved for certification, their firms and firms’ affiliated companies may provide non-certification services to our company and subsidiaries		All presented members agreed to approve and submit it to the Board of Directors. It was approved by all presented Directors without any objections.
The 17th Session of the Second Meeting
2023/05/03		1. The Company’s consolidated financial statements for the first quarter of 2023
2. The company’s operating budget for 2023
3. Amend some provisions of the company’s “Rules of Procedure for Shareholders’ Meetings”
4. The company plans to handle the case of guaranteed issuance of commercial promissory notes
5. Cases in which the company and its subsidiaries intend to lend funds to their subsidiaries
6. The company plans to increase its capital in Taihan Mold Products (Dongguan) Co., Ltd. by US$3.5 million.		All presented members agreed to approve and submit it to the Board of Directors. It was approved by all presented Directors without any objections.
The 1th Session of the Third Meeting
2023/06/19		1. Select the convener of the third audit committee
2. The subsidiary Yonghan Precision Technology Co., Ltd. plans to build a new factory for operation and use		All presented members agreed to approve and submit it to the Board of Directors. It was approved by all presented Directors without any objections.
The 2th Session of the Third Meeting
2023/08/08		1. The company’s consolidated financial statements for the second quarter of 2023
2. The company and its subsidiaries plan to handle short-term financing quota cases
3. The company's subsidiary plans to apply for short-term financing from the bank, and the company plans to endorse it.
4. Cases in which the company and its subsidiaries intend to lend funds to their subsidiaries		All presented members agreed to approve and submit it to the Board of Directors. It was approved by all presented Directors without any objections.
The 3th Session of the Third Meeting
2023/11/03		1. The company and its subsidiaries plan to handle short-term financing quota cases
2. The company's subsidiary plans to apply for short-term financing from the bank, and the company plans to endorse it.
3. Cases in which the company and its subsidiaries intend to lend funds to their subsidiaries
4. The company’s 2024 audit plan
5. The company plans to revise the "Salary Work Cycle - Appointment Operations", "Salary Work Cycle - Education and Training Operations", "Salary Work Cycle - Attendance Operations", "Salary Work Cycle - Assessment and Reward and Punishment Operations", "Salary Work Cycle - "Personnel Change Operations", "Computerized Information System Management Cycle - Access Control of Programs and Data", "Computerized Information System Management Cycle - Security Control of Files and Equipment", and "Internal Major Information Processing Operation Procedures".		All presented members agreed to approve and submit it to the Board of Directors. It was approved by all presented Directors without any objections.
The 4th Session of the Third Meeting
2023/11/06		1. The Company’s consolidated financial statements for the third quarter of 2023All presented members agreed to approve and submit it to the Board of Directors. It was approved by all presented Directors without any objections.

Note: Except for the mentioned agenda items, no other agenda items were approved by the Audit Committee, but have been approved by two-thirds of all Board of Directors.

The Communications between the Independent Directors, Internal Auditors, and Independent Auditors

DateCommunication Highlight SummaryCommunication Results
2023/03/16 Communication with governance units for this and other projects.No comments for this meeting.
Scroll to Top